Cancer research and treatment development require a harmonized approach due to the complex and global nature of cancer clinical trials. The ICH guidelines provide a framework for conducting these trials consistently and rigorously across different regions. This harmonization helps in accelerating the development of new cancer therapies and ensures that the resulting data is reliable and comparable globally.
